[
    [
        {
            "time": "",
            "original_text": "【国金策略】1月“外资”持股市值及结构剖析|| 疫情引发外资净流出，月整体加仓“TMT、医药”（李立峰/丁潇等）",
            "features": {
                "keywords": [
                    "外资",
                    "疫情",
                    "净流出",
                    "TMT",
                    "医药",
                    "加仓"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "TMT",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【国金策略】1月“外资”持股市值及结构剖析|| 疫情引发外资净流出，月整体加仓“TMT、医药”（李立峰/丁潇等）",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "丽珠集团：丽珠微球平台国内第一，品种集中进入临床，研发进度加速【国盛医药张金洋团队】",
            "features": {
                "keywords": [
                    "丽珠集团",
                    "微球平台",
                    "临床",
                    "研发进度",
                    "加速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "丽珠集团：丽珠微球平台国内第一，品种集中进入临床，研发进度加速【国盛医药张金洋团队】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]